{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:53:30Z","timestamp":1769550810371,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clgc.2024.102132","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:32:20Z","timestamp":1717140740000},"page":"102132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0494-7839","authenticated-orcid":false,"given":"Mario","family":"de Angelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Siech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-0519","authenticated-orcid":false,"given":"Letizia Maria Ippolita","family":"Jannello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8585-3701","authenticated-orcid":false,"given":"Francesco Di","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3057-3805","authenticated-orcid":false,"given":"Natali Rodriguez","family":"Pe\u00f1aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar","family":"Touma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Micali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clgc.2024.102132_bib0001","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN Guidelines\u00ae insights: bladder Cancer, Version 2.2022","volume":"20","author":"Flaig","year":"2022","journal-title":"J Nat Comprehens Canc Netw"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.clgc.2024.102132_bib0003","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.1998.16.11.3576","article-title":"Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03","volume":"16","author":"Shipley","year":"1998","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102132_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/003655902762467567","article-title":"Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer - nordic cystectomy trial 2","volume":"36","author":"Sherif","year":"2002","journal-title":"Scand J Urol Nephrol"},{"issue":"16","key":"10.1016\/j.clgc.2024.102132_bib0005","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clgc.2024.102132_bib0006","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0007","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eururo.2021.09.028","article-title":"Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"81","author":"Burdett","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1464-410X.2006.05859.x","article-title":"Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer","volume":"97","author":"Lehmann","year":"2006","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005392-199501000-00019","article-title":"Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience","volume":"153","author":"Stockle","year":"1995","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5347(17)32822-7","article-title":"Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial","volume":"152","author":"Studer","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102132_bib0011","first-page":"533","article-title":"Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group","volume":"303","author":"Bono","year":"1989","journal-title":"Prog Clin Biol Res"},{"issue":"4","key":"10.1016\/j.clgc.2024.102132_bib0012","first-page":"279","article-title":"Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer","volume":"8","author":"Skinner","year":"1990","journal-title":"Semin Urol"},{"issue":"25","key":"10.1016\/j.clgc.2024.102132_bib0013","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1200\/JCO.2010.34.4028","article-title":"Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status","volume":"29","author":"Stadler","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2024.102132_bib0014","unstructured":"The R project for statistical computing, https:\/\/www.r-project.org."},{"issue":"5","key":"10.1016\/j.clgc.2024.102132_bib0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.23736\/S2724-6051.19.03657-9","article-title":"Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis","volume":"73","author":"Jue","year":"2021","journal-title":"Minerva Urol Nephrol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102132_bib0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clgc.2019.12.011","article-title":"Comparison of neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer","volume":"18","author":"Macleod","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2024.102132_bib0017","doi-asserted-by":"crossref","first-page":"330","DOI":"10.21037\/tau-23-79","article-title":"Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database","volume":"12","author":"Tan","year":"2023","journal-title":"Transl Androl Urol"},{"issue":"9","key":"10.1016\/j.clgc.2024.102132_bib0018","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.urology.2013.07.072","article-title":"Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the national cancer database","volume":"83","author":"Zaid","year":"2014","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.eururo.2014.01.009","article-title":"Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides","volume":"67","author":"Reardon","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102132_bib0021","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4111\/icu.20200132","article-title":"Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer","volume":"61","author":"McFerrin","year":"2020","journal-title":"Investig Clin Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102132_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clgc.2019.10.012","article-title":"Increasing rates of perioperative chemotherapy are associated with improved survival in men with urothelial bladder cancer with prostatic stromal invasion","volume":"18","author":"Rosiello","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"15_suppl","key":"10.1016\/j.clgc.2024.102132_bib0023","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1200\/JCO.2016.34.15_suppl.4524","article-title":"Adjuvant versus neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC): analysis of the National Cancer Database (NCDB)","volume":"34","author":"Sonpavde","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:56:50Z","timestamp":1738565810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1558767324001034"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102132","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102132"}}